Company profile: Assembly Bio
1.1 - Company Overview
Company description
- Provider of oral biologic therapeutics focused on antiviral drug development, including a next-generation capsid assembly modulator for HBV to disrupt replication and prevent new cccDNA, an HBV/HDV pipeline with small molecule inhibitors and interferon-α receptor agonists, and a herpesvirus portfolio targeting high-recurrence genital herpes and transplant-associated herpesviruses, with clinical trials of ABI-H3733 and ABI-4334.
Products and services
- Clinical Trials: Studies conducted to evaluate safety, pharmacokinetics, and antiviral activity of investigational chronic HBV therapies, including ABI-H3733 and ABI-4334
- HBV/HDV Research Pipeline: Programs architected to deliver finite and curative HBV therapies and treat HDV using small-molecule inhibitors and interferon-α receptor agonists
- Next-Generation Capsid Assembly Modulator (CAM): A clinical-stage antiviral candidate engineered to disrupt HBV replication and prevent formation of new cccDNA by modulating capsid assembly
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Assembly Bio
Adaptive Phage Therapeutics
HQ: United States
Website
- Description: Provider of phage-based therapeutic services for multi-drug resistant pathogenic bacteria, using clinical technology to match phages to patient-specific infections; offerings include BX004 for cystic fibrosis Pseudomonas aeruginosa, BX211 for diabetic foot osteomyelitis, personalized and optimized phage therapies, and the XMarker platform for microbial biomarker discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adaptive Phage Therapeutics company profile →
BioCare Copenhagen
HQ: Denmark
Website
- Description: Provider of dietary supplements with microbial components for gastrointestinal problems, infections, and immune enhancement; offers medical nutrition, early life nutrition, pharma solutions, and nutrition improvement. Products include Humiome B2, supporting gut health by delivering a high percentage of vitamin B2 to the colon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCare Copenhagen company profile →
MicuRx Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel antimicrobials for drug-resistant infections. Portfolio includes Contezolid (MRX-I), an oxazolidinone for complicated skin and soft tissue infections (targets MRSA, VRE); Contezolid acefosamil (MRX-4), an injectable oxazolidinone in Phase III; MRX-8, a polymyxin for multidrug-resistant Gram-negative; MRX-5, a boron compound; MRX-7, a pleuromutilin inhibitor; and MRX-15, a kidney-targeted therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MicuRx Pharmaceuticals company profile →
Seres Therapeutics
HQ: United States
Website
- Description: Provider of microbiome therapeutics, including VOWST, an FDA-approved oral microbiota-based therapy to prevent recurrent Clostridioides difficile infection in adults after antibacterial treatment; SER-155, an investigational oral microbiome therapeutic aimed at reducing gastrointestinal infections, bacteremia, and graft versus host disease in immunocompromised patients; and a platform to design, test, and manufacture bacterial consortia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seres Therapeutics company profile →
Infinant Health
HQ: United States
Website
- Description: Provider of infant gut microbiome solutions, offering Evivo Powder, a daily supplement for infants fed any amount of breast milk to establish a protective gut microbiome and support healthy immune function, and B. infantis EVC001, a bacterial strain discovered by Infinant Health and proven pivotal to infant immune health, particularly when combined with breast milk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infinant Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Assembly Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Assembly Bio
2.2 - Growth funds investing in similar companies to Assembly Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Assembly Bio
4.2 - Public trading comparable groups for Assembly Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →